A psychedelic pathway toward PTSD recovery

Post traumatic stress disorder (PTSD) is one of the most common conditions facing U.S. Veterans, and there is currently no effective cure—what’s more, many Veterans use alcohol in an effort to alleviate their trauma, making their medical treatment even more complex. For these high risk patients, two professors at Brown are thinking outside the box: Could a treatment involving psychedelic drugs potentially save Veteran lives?

In this episode, Megan speaks to Professors Christy Capone and Carolina Haass-Koffler, part of a team at Brown running the first study of a promising new treatment that combines therapy with MDMA (aka the party drug molly, or ecstasy) for Veterans with PTSD and alcohol use disorder. The researchers explain the science guiding their study, why they believe this treatment could be a game-changer and the upcoming FDA decision regarding MDMA’s role in medicine.